ProKidney Stock (NASDAQ: PROK) stock price, news, charts, stock research, profile.
Open | $2.160 |
Close | - |
Volume / Avg. | 623.714K / 720.241K |
Day Range | 2.160 - 2.460 |
52 Wk Range | 1.120 - 13.510 |
Market Cap | $136.140M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 22.8% |
Days to Cover | 34.95 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ProKidney (NASDAQ: PROK) through any online brokerage.
Other companies in ProKidney’s space includes: Molecular Partners (NASDAQ:MOLN), Syros Pharmaceuticals (NASDAQ:SYRS), Vistagen Therapeutics (NASDAQ:VTGN), Tevogen Bio Holdings (NASDAQ:TVGN) and Adicet Bio (NASDAQ:ACET).
The latest price target for ProKidney (NASDAQ: PROK) was reported by Morgan Stanley on Thursday, March 7, 2024. The analyst firm set a price target for 3.00 expecting PROK to rise to within 12 months (a possible 25.98% upside). 3 analyst firms have reported ratings in the last year.
The stock price for ProKidney (NASDAQ: PROK) is $2.3813 last updated Today at April 29, 2024 at 2:32 PM EDT.
There are no upcoming dividends for ProKidney.
ProKidney’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for ProKidney.
ProKidney is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.